Nucleosides and nucleotides remain one of the most fruitful drug classes, providing about 50% of antiviral drugs and 20% of cancer drugs used in the UK. Nucleoside and nucleotide chemistry constitute a vibrant field of research for both synthetic and biological chemists.
This meeting will bring together scientists at the interface of synthetic chemistry and biology to tackle current challenges and celebrate recent achievements in the field.
This meeting will bring together scientists at the interface of synthetic chemistry and biology to tackle current challenges and celebrate recent achievements in the field.
Deadlines
Useful links
Downloads
-
First announce-web.pdf
-
Registration form
-
ProTides and phosphorodiamidates as nucleotide pro-drug forms: from the lab to clinical use
-
Developing prodrugs of antivirally active nucleoside triphosphates. Against all odds - it works!
-
Second announcement
-
Final announcement
-
Registration form
-
Application of green technologies for nucleic acid transformations, Yogesh Sanghvi
-
Aptamers: novel oligonucleotide reagents for disease diagnosis and therapy, David Bunka
